343 related articles for article (PubMed ID: 23263341)
21. Model for end-stage liver disease score versus simplified acute physiology score criteria in acute renal failure after liver transplantation.
Umbro I; Tinti F; Mordenti M; Rossi M; Ianni S; Pugliese F; Ruberto F; Ginanni Corradini S; Nofroni I; Poli L; Berloco PB; Mitterhofer AP
Transplant Proc; 2011 May; 43(4):1139-41. PubMed ID: 21620072
[TBL] [Abstract][Full Text] [Related]
22. Model for end-stage liver disease predicts right ventricular failure in patients with left ventricular assist devices.
Yost GL; Coyle L; Bhat G; Tatooles AJ
J Artif Organs; 2016 Mar; 19(1):21-8. PubMed ID: 26187243
[TBL] [Abstract][Full Text] [Related]
23. Risk factors predictive of right ventricular failure after left ventricular assist device implantation.
Drakos SG; Janicki L; Horne BD; Kfoury AG; Reid BB; Clayson S; Horton K; Haddad F; Li DY; Renlund DG; Fisher PW
Am J Cardiol; 2010 Apr; 105(7):1030-5. PubMed ID: 20346326
[TBL] [Abstract][Full Text] [Related]
24. Risk of mortality for ventricular arrhythmia in ambulatory LVAD patients.
Brenyo A; Rao M; Koneru S; Hallinan W; Shah S; Massey HT; Chen L; Polonsky B; McNitt S; Huang DT; Goldenberg I; Aktas M
J Cardiovasc Electrophysiol; 2012 May; 23(5):515-20. PubMed ID: 22081967
[TBL] [Abstract][Full Text] [Related]
25. Pre-operative mortality risk assessment in patients with continuous-flow left ventricular assist devices: application of the HeartMate II risk score.
Thomas SS; Nahumi N; Han J; Lippel M; Colombo P; Yuzefpolskaya M; Takayama H; Naka Y; Uriel N; Jorde UP
J Heart Lung Transplant; 2014 Jul; 33(7):675-81. PubMed ID: 24726424
[TBL] [Abstract][Full Text] [Related]
26. The use of APACHE II scores to select candidates for left ventricular assist device placement. Acute Physiology and Chronic Health Evaluation.
Gracin N; Johnson MR; Spokas D; Allen J; Bartlett L; Piccione W; Parrillo JE; Costanzo MR; Calvin JE
J Heart Lung Transplant; 1998 Oct; 17(10):1017-23. PubMed ID: 9811411
[TBL] [Abstract][Full Text] [Related]
27. The predictive value of postoperative clinical risk scores for outcome after hepatic resection: a validation analysis in 807 patients.
Rahbari NN; Reissfelder C; Koch M; Elbers H; Striebel F; Büchler MW; Weitz J
Ann Surg Oncol; 2011 Dec; 18(13):3640-9. PubMed ID: 21674269
[TBL] [Abstract][Full Text] [Related]
28. Present-Day Hospital Readmissions after Left Ventricular Assist Device Implantation: A Large Single-Center Study.
Hernandez RE; Singh SK; Hoang DT; Ali SW; Elayda MA; Mallidi HR; Frazier OH; Meyers DE
Tex Heart Inst J; 2015 Oct; 42(5):419-29. PubMed ID: 26504434
[TBL] [Abstract][Full Text] [Related]
29. [Correlations between MELD score and left ventricular function in patients with end-stage liver disease].
Sun FR; Meng YM; Wang BY; Liu YF; Liu CX; Xie DW; Ding YY; Li JP; Ma L
Zhonghua Gan Zang Bing Za Zhi; 2010 Oct; 18(10):758-62. PubMed ID: 21059293
[TBL] [Abstract][Full Text] [Related]
30. Neurohormonal regulation and improvement in blood glucose control: reduction of insulin requirement in patients with a nonpulsatile ventricular assist device.
Koerner MM; El-Banayosy A; Eleuteri K; Kline C; Stephenson E; Pae W; Ghodsizad A
Heart Surg Forum; 2014 Apr; 17(2):E98-102. PubMed ID: 24808450
[TBL] [Abstract][Full Text] [Related]
31. Significance of postoperative acute renal failure after continuous-flow left ventricular assist device implantation.
Borgi J; Tsiouris A; Hodari A; Cogan CM; Paone G; Morgan JA
Ann Thorac Surg; 2013 Jan; 95(1):163-9. PubMed ID: 23103012
[TBL] [Abstract][Full Text] [Related]
32. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
[TBL] [Abstract][Full Text] [Related]
33. Comparison of hepatic venous pressure gradient and two models of end-stage liver disease for predicting the survival in patients with decompensated liver cirrhosis.
Suk KT; Kim CH; Park SH; Sung HT; Choi JY; Han KH; Hong SH; Kim DY; Yoon JH; Kim YS; Baik GH; Kim JB; Kim DJ
J Clin Gastroenterol; 2012; 46(10):880-6. PubMed ID: 22810110
[TBL] [Abstract][Full Text] [Related]
34. Predictors and outcomes of continuous veno-venous hemodialysis use after implantation of a left ventricular assist device.
Topkara VK; Dang NC; Barili F; Cheema FH; Martens TP; George I; Bardakci H; Oz MC; Naka Y
J Heart Lung Transplant; 2006 Apr; 25(4):404-8. PubMed ID: 16563969
[TBL] [Abstract][Full Text] [Related]
35. Impact of Postoperative Liver Dysfunction on Survival After Left Ventricular Assist Device Implantation.
Majumder K; Spratt JR; Holley CT; Roy SS; Cogswell RJ; Liao K; John R
Ann Thorac Surg; 2017 Nov; 104(5):1556-1562. PubMed ID: 28760474
[TBL] [Abstract][Full Text] [Related]
36. Device exchange after primary left ventricular assist device implantation: indications and outcomes.
Stulak JM; Cowger J; Haft JW; Romano MA; Aaronson KD; Pagani FD
Ann Thorac Surg; 2013 Apr; 95(4):1262-7; discussion 1267-8. PubMed ID: 23063192
[TBL] [Abstract][Full Text] [Related]
37. Delayed reversal of impaired metabolic vasodilation in patients with end-stage heart failure during long-term circulatory support with a left ventricular assist device.
Khan T; Levin HR; Oz MC; Katz SD
J Heart Lung Transplant; 1997 Apr; 16(4):449-53. PubMed ID: 9154956
[TBL] [Abstract][Full Text] [Related]
38. Non-cardiac surgery in patients on long-term left ventricular assist device support.
Morgan JA; Paone G; Nemeh HW; Henry SE; Gerlach B; Williams CT; Lanfear DE; Tita C; Brewer RJ
J Heart Lung Transplant; 2012 Jul; 31(7):757-63. PubMed ID: 22425233
[TBL] [Abstract][Full Text] [Related]
39. Pre-operative risk factors of bleeding and stroke during left ventricular assist device support: an analysis of more than 900 HeartMate II outpatients.
Boyle AJ; Jorde UP; Sun B; Park SJ; Milano CA; Frazier OH; Sundareswaran KS; Farrar DJ; Russell SD;
J Am Coll Cardiol; 2014 Mar; 63(9):880-8. PubMed ID: 24316083
[TBL] [Abstract][Full Text] [Related]
40. Does pretransplant left ventricular assist device therapy improve results after heart transplantation in patients with elevated pulmonary vascular resistance?
Liden H; Haraldsson A; Ricksten SE; Kjellman U; Wiklund L
Eur J Cardiothorac Surg; 2009 Jun; 35(6):1029-34; discussion 1034-5. PubMed ID: 19211259
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
